Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Capital Employed: 2019-2025

Historic Return on Capital Employed for Autolus Therapeutics (AUTL) over the last 5 years, with Sep 2025 value amounting to -0.45%.

  • Autolus Therapeutics' Return on Capital Employed fell 17.00% to -0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.45%, marking a year-over-year decrease of 17.00%. This contributed to the annual value of -0.47% for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Autolus Therapeutics reported Return on Capital Employed of -0.45% as of Q3 2025, which was down 10.90% from -0.41% recorded in Q2 2025.
  • Autolus Therapeutics' Return on Capital Employed's 5-year high stood at -0.23% during Q2 2024, with a 5-year trough of -141.53% in Q3 2021.
  • For the 3-year period, Autolus Therapeutics' Return on Capital Employed averaged around -0.35%, with its median value being -0.32% (2024).
  • Per our database at Business Quant, Autolus Therapeutics' Return on Capital Employed plummeted by 14,105bps in 2021 and then surged by 14,099bps in 2022.
  • Over the past 5 years, Autolus Therapeutics' Return on Capital Employed (Quarterly) stood at -122.39% in 2021, then skyrocketed by 12,202bps to -0.38% in 2022, then dropped by 14bps to -0.52% in 2023, then increased by 20bps to -0.32% in 2024, then declined by 17bps to -0.45% in 2025.
  • Its Return on Capital Employed was -0.45% in Q3 2025, compared to -0.41% in Q2 2025 and -0.38% in Q1 2025.